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Abstract
Rationale Repeated exposure to psychostimulant drugs
causes a long-lasting increase in the psychomotor and
reinforcing effects of these drugs and an array of neuro-
adaptations. One such alteration is a hypersensitivity of
striatal activity such that a low dose of amphetamine in
sensitized animals produces dorsal striatal activation patterns
similar to acute treatment with a high dose of amphetamine.
Objectives To extend previous findings of striatal hyper-
sensitivity with behavioral observations and with cellular
activity in the nucleus accumbens and prefrontal cortex in
sensitized animals.
Materials and methods Rats treated acutely with 0, 1, 2.5,
or 5 mg/kg i.p. amphetamine and sensitized rats challenged
with 1 mg/kg i.p. amphetamine were scored for stereotypy,
rearing, and grooming, and locomotor activity recorded. c-fos
positive nuclei were quantified in the nucleus accumbens and
prefrontal cortex after expression of sensitization with
1 mg/kg i.p. amphetamine.
Results Intense stereotypy was seen in animals treated
acutely with 5 mg/kg amphetamine, but not in the
sensitized group treated with 1 mg/kg amphetamine. The
c-fos response to amphetamine in the accumbens core was
augmented in amphetamine-pretreated animals with a shift
in the distribution of optical density, while no effect of
sensitization was seen in the nucleus accumbens shell or
prefrontal cortex.
Conclusions A lack of stereotypy in the sensitized group
indicates a dissociation of behavioral responses to amphet-
amine and striatal immediate-early gene activation patterns.
The increase in c-fos positive nuclei and shift in the
distribution of optical density observed in the nucleus
accumbens core suggests recruitment of a new population
of neurons during expression of sensitization.
Keywords Behavioralsensitization.Immediate-earlygene.
Stereotypy.Locomotion.Striatum.Prefrontalcortex
Introduction
Repeated exposure to psychostimulant drugs causes a long-
lasting enhancement of certain behavioral responses to the
drug, such as psychomotor activity and stereotypy, and
behaviors related to incentive motivation, a process termed
behavioral sensitization (Stewart and Badiani 1993). Be-
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e-mail: r.e.nordquist@uu.nlhavioral sensitization is known to be associated with long-
lasting functional changes within limbic corticostriatal
systems (Pierce and Kalivas 1997; Robinson and Kolb
2004; Vanderschuren and Kalivas 2000). These systems
comprise functionally and anatomically heterogeneous
areas with a fine-grained specificity of anatomical projec-
tions connecting the divisions within the dorsal striatum,
ventral striatum, and prefrontal cortex (Groenewegen et al.
1997; Voorn et al. 2004). This anatomical and functional
heterogeneity is of potential importance to the roles of these
areas in sensitization.
Within the dorsal striatum, subareas termed patches (or
striosomes) show more reactivity to amphetamine than the
surrounding matrix areas in sensitized animals (Canales and
Graybiel 2000; Vanderschuren et al. 2002). Our previous
studies demonstrated that this pattern of neuronal reactivity
is also seen in acutely challenged animals with the important
difference that sensitized animals show preferential activa-
tion in patches at much lower doses of amphetamine than
those required to produce this type of differentiation in
activation in drug-naive animals (Vanderschuren et al.
2002). An imbalance in patch–matrix activation has been
suggested to underlie stereotyped behavior (Canales and
Graybiel 2000). Because our drug treatment regimen caused
robust locomotor sensitization, which is incompatible with
profound stereotypy, we hypothesized that hyperreactivity
of patch compartments is not sufficient to produce stereo-
typy (Vanderschuren et al. 2002). To extend our previous
findings, we ran new experiments using the same doses
and regimen of amphetamine administration previously used
and measured locomotor activity, stereotypy, grooming, and
rearing to establish whether our drug treatment regimen,
which causes hyperreactivity of dorsal striatal patches,
produces stereotypy.
The ventral striatum, specifically the nucleus accumbens
(Acb), and the prefrontal cortex (PFC) are both involved
in behavioral sensitization (Pierce and Kalivas 1997;
Vanderschuren and Kalivas 2000), an involvement which
has received particular attention because of the important
role that both areas play in appetitive and consummatory
properties of both natural and drug rewards (Everitt and
Wolf 2002; Robbins and Everitt 2002; Salamone et al.
2003; Volkow and Li 2004). There are functional differ-
ences between subregions within both the Acb, i.e., core
and shell, and within subregions of the PFC (Cardinal et al.
2002; Robbins and Everitt 2002). However, there is
presently inconclusive evidence on the respective roles that
the subregions play during the expression of behavioral
sensitization to psychostimulants. Studies using neuro-
chemistry, lesions, cellular activity markers, and study of
morphological changes have suggested exclusive roles for
the core (Cadoni et al. 2000; Li et al. 2004; Phillips et al.
2003) or the shell (Filip and Siwanowicz 2001; Hsieh et al.
2002; Pierce and Kalivas 1995; Todtenkopf et al. 2002a).
Other studies, including previous work from our own
laboratory, suggest a lack of sensitization of accumbens
activity all together (Ostrander et al. 2003; Vanderschuren
et al. 2002). The medial PFC, and particularly the prelimbic
area, has been implicated in induction of psychostimulant
sensitization (Tzschentke and Schmidt 1998, 2000),
although conflicting results have been found for cocaine-
vs. amphetamine-induced sensitization (Tzschentke and
Schmidt 2000). The dorsomedial prefrontal cortex has been
shown to be involved in the expression of sensitization
(Pierce et al. 1998). However, the roles of the orbital and
lateral areas in psychostimulant sensitization remain to be
investigated. Thus, clarification of the specific roles of the
Acb and PFC subregions is needed. To study the activation
of the Acb and PFC in detail during the expression of
behavioral sensitization, we examined levels of c-fos-like
proteins (henceforth c-fos) in detail in the subregions of the
Acb and PFC of the rat after an amphetamine challenge in
behaviorally sensitized rats.
Materials and methods
Animals and drug treatments
All experiments were approved by the Animal Ethics
Committee of the Vrije Universiteit and were conducted
in agreement with Dutch laws (Wet op de Dierproeven
1996) and European regulations (Guideline 86/609/EEC).
A total of 48 male Wistar rats weighing 180–200 g upon
arrival in the laboratory (as in, e.g., De Vries et al. 1996;
Vanderschuren et al. 1999a, b, 2002) were housed in
Macrolon cages in groups of two animals per cage under
controlled laboratory conditions (lights on 0700 to 1900
hours). Food and water were available ad libitum. Drug
treatment started after an acclimatization period of at least
1 week. Animals were briefly handled during the 2 days
before all injections. In the acute amphetamine experi-
ments, animals were injected with either saline or 1, 2.5, or
5m g / k gD-amphetamine sulfate (O.P.G., Utrecht, The
Netherlands; n=4 per dose). Sensitization regimens were
according to a protocol previously established to produce
locomotor sensitization in our laboratory (De Vries et al.
1996; Vanderschuren et al. 1999a, b), and doses were the
same as used previously in a c-fos study in our laboratory
(Vanderschuren et al. 2002). Animals received once daily
injections for five consecutive days of 2.5 mg/kg D-
amphetamine sulfate or saline in the home cage (pretreat-
ment phase). Two weeks post treatment, half of the
animals from each pretreatment group were given chal-
lenge injections of 1 mg/kg D-amphetamine sulfate while
the other half was injected with saline. This gave a total of
114 Psychopharmacology (2008) 198:113–126four experimental groups, n=8 per group: amphetamine-
pretreated, amphetamine-challenged (AA); amphetamine-
pretreated, saline-challenged (AS); saline-pretreated,
amphetamine-challenged (SA); and saline-pretreated, saline-
challenged (SS).
Locomotor activity quantification and behavioral scoring
All injections for the acute experiments and challenge
injections for the sensitization experiments took place in
our locomotor activity setup. On the challenge injection
day, animals were first placed in the Perspex cages
(length×width×height=40×40×35 cm) in which locomo-
tor activity was measured and allowed to acclimate for 2 h.
After that period, challenge injections were administered
and horizontal activity was measured in 10-min blocks for
90 min using a video tracking system (EthoVision, Noldus
Information Technology B.V., Wageningen, The Nether-
lands), which determined the position of the animal five
times per second. Behavior of the animals was also
videotaped and scored afterwards for three mutually
exclusive categories: grooming (rubbing two paws over
head and/or body), rearing (both front paws off of the
ground but not grooming), or stereotypical behavior
(repeated movements without horizontal movement, e.g.,
head shaking). Behavior was scored for 5 min of every
15 min, giving a total of seven measurements per animal,
by an observer unaware of the treatment of the animals
using a time-sampling program written in PC Basic. Time
spent performing each behavior was expressed as the
percentage of total time for each 5-min block. Replication
scoring several months after initial scoring produced results
identical to initial observations, demonstrating the reliability
of our scoring procedures.
c-fos Immunocytochemistry
At 90 min after the challenge injection, animals were
decapitated, the brains were snap-frozen in isopentane and
stored at −80°C until use. Sections of 20 μm were cut on a
cryostat and mounted onto coated slides (SuperFrost Plus)
which were dried and stored at −80°C until use. For
visualization of c-fos, sections were defrosted and fixed in a
4% paraformaldehyde solution in phosphate-buffered saline
(PBS; 0.1 M, pH 7.4). Sections were washed with Tris-
buffered saline (TBS, 0.1 M, pH 7.4) then incubated with
primary antibody against c-fos (1:1,800, Oncogene Re-
search, Burlington, MA, USA) in TBS with 0.5% Triton-X
and 0.5% bovine serum albumin (TBS-TX-BSA) overnight
at 4°C. After rinsing with TBS, endogenous peroxidase
activity was removed by incubation of sections in a 1%
hydrogen peroxide solution for 15 min. Sections were
rinsed with TBS, then incubated in biotinylated goat
antirabbit antibody (1:100, Dako, Denmark) in TBS-TX-
BSA for 1 h, washed in TBS and incubated in avidin–biotin
complex with horseradish peroxidase (HRP) (1:100, Vector
Laboratories, Burlingame, CA, USA) for 1 h. Sections were
rinsed in Tris–HCl then incubated in 3′3-diaminobenzidine
(DAB; Sigma Chemical, 0.05% DAB in Tris–HCl) and
rinsed in Tris–HCl. Sections containing the prefrontal
cortex were incubated with Hoechst 33258 (1:2,000;
Molecular Probes, Eugene, OR, USA), a fluorescent
nuclear stain used to visualize cytoarchitecture. Sections
were dried and finally coverslipped with Merckoglas
(Merck, Darmstadt, Germany).
Histological quantification
Quantificationofc-fos immunopositive nuclei was performed
using an MCID Elite imaging system (Imaging Research,
Ontario, Canada). Images of the nucleus accumbens in the c-
fos DAB immunostained sections were digitized using an
objective magnification of ×10 on a Leica DM/RBE photo-
microscope with a Xillix MicroImager digital camera
(1,280×1,024 pixels). Digitized images were combined so
that the core and the shell areas were included, using the
MCID tiling tool. Three (in some cases, two) sections per rat
were chosen for quantification at the rostral–caudal levels in
which inputs from the prefrontal cortex, thalamus, and
amygdala have been particularly well characterized (Wright
and Groenewegen 1995). The prefrontal cortex was digitized
in the same fashion with the exception that color digital
images were acquired using a Sony HAD camera (Sony
DXC 950v, 640×512 pixels) of both the DAB staining and
the epifluorescence of the Hoechst 33258 staining. The core
and shell areas of the nucleus accumbens were delineated on
the basis of atlas drawings from sections stained for
calbindin (Jongen-Relo et al. 1993). The prefrontal cortex
was delineated into prelimbic, infralimbic, orbital, and lateral
areas on the basis of cytoarchitectonic criteria visible in the
Hoechst 33258 staining.
The c-fos immunopositivenucleiinthenucleusaccumbens
were segregated from background staining levels using
several point operators and spatial filters combined in an
algorithm designed to detect local changes in the relative
optical density (ROD). Briefly, images underwent histogram
equalization and smoothing (low-pass filter, kernel size
7×7). The unfiltered image was subtracted from the
smoothed image, followed by a series of steps to optimize
the processed image and make it a suitable measuring
template for detecting objects the size and shape of c-fos
immunopositive nuclei. This algorithm was preferred over
ROD thresholding because it does not involve an observer-
dependent operation. The number of nuclei counted was
corrected with a factor indicating approximate size of a c-
fos immunopositive nucleus, thus preventing two groups of
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mistakenly counted as one nucleus. The results of all
counting were expressed as the number of nuclei per
surface area (mm
2). Integrated ROD for each segmented
immunopositive nucleus was determined. Segregation of c-
fos positive nuclei in the color-digitized images was
performed in a similar fashion.
Subsequently, we set out to compare c-fos positive
density (i.e., the number of cells per surface area) in a
manner that accounts for labeling intensity: dark, light, or
midrange. First, histograms of c-fos nuclei ROD values (for
black and white images) or intensity values (for color
images) were constructed for each brain area for each
treatment group and qualitatively compared. These histo-
grams were used to determine the value of the 33rd and
66th percentile optical density within the SS group. Based
on these values, all nuclei from all animals for each area
were binned as “light” (ROD values under the 33rd
percentile of the SS group), “midrange” (ROD values
between the 33rd and 66th percentile of the SS group) or
“dark” (ROD values above the 66th percentile of the SS
group). The number of immunopositive nuclei per bin was
counted per rat, and the group averages were determined
from the rat averages. For the prefrontal cortex, the same
technique was used, but as these areas were digitized in
color, intensity was used to bin rather than optical density.
An increase in the number of nuclei in the “dark” bin would
signify a rightward shift in the histograms, indicating that
the increased cellular activity measured was primarily the
result of more c-fos expression in the same group of
neurons. An increase in the number of nuclei in the
“midrange” bin would signify an upward shift in the
histograms, indicating that the increase in the total number
of nuclei measured was the result of the addition of a new
group of nuclei to the cellular response (Fig. 1).
The dorsal striatum of the AA group was qualitatively
inspected by two observers, both blind to the experimental
conditions. The distribution pattern of c-fos positive nuclei
was described and compared with that in a series of closely
adjacent sections from the same animals stained immuno-
cytochemically for the μ-opioid receptor to visualize striatal
patches (Vanderschuren et al. 2002).
Statistics
For the quantification of c-fos immunoreactivity, the
experimental groups were compared for effects of pretreat-
ment and challenge (saline vs. amphetamine) and for
interactions between these effects using a two-way ANOVA
test followed by a Tukey post hoc test. For locomotor
activity and behavioral scores, a repeated-measures ANOVA
was conducted using time as within-subjects factor and
followed by a Tukey post hoc test.
Results
Behavioral results
For all behavioral measures, time was included as a within-
subjects measure in a repeated-measures ANOVA followed
by a post hoc test when significant time×pretreatment or
time×challenge interactions were found. For brevity, only
the most relevant of the results of these post hoc test results
are described in this section and other results are presented
in the figures.
Behavioral measures: responses to acute amphetamine
Locomotor activity was dose-dependently altered in ani-
mals treated acutely with amphetamine (Fig. 2a; main effect
dose F(3,10)=43.914; p<0.001). Saline-treated animals
showed generally low activity levels, averaging a total of
1,335±514 cm traveled during the 90-min period. The
groups treated with 1 mg/kg (14,045±1,836 cm) and 5 mg/kg
amphetamine (14,906±2,321 cm) showed comparable levels
Fig. 1 Theoretical conceptualization of shifts in the ROD histograms.
The total number of c-fos positive nuclei per mm
2 counted is
represented as the area under the curves to the right of the detection
level, indicated as an arrow on the x-axis. Curve 1 indicates the
control group; vertical lines indicate the ROD used to separate the
neurons into light, midrange, and dark. An increase in the treatment
group compared to the control group in the total number of c-fos
positive nuclei per mm
2 could be the result of an increase in the
frequency of c-fos positive nuclei, indicated by an increase in
frequency in curve 2, causing an increase in the number of c-fos
positive nuclei in the midrange. This would indicate that a new group
of neurons is being recruited in the c-fos response, represented by the
difference between curves 1 and 2 in frequency. Alternatively, the
same number of neurons could be active, but expressing more c-fos
protein. This would cause a rightward shift in the curve (curve 3) and
allowing more c-fos positive nuclei to come above the detection level
and causing more c-fos positive nuclei to be measured in the dark
range. A similar line of reasoning can be followed for other options,
for instance a leftward shift in the case of reduced levels of c-fos
protein (not illustrated)
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to amphetamine was observed in the 2.5 mg/kg group
(25,543±1,704 cm). All amphetamine-treated groups differed
from saline in the post hoc test. Acute amphetamine caused a
significant increase in rearing (F(3,12)=7.971; p<0.005;
Fig. 2b), although not dose-dependently, as all doses differed
significantly from the saline-treated group in post hoc testing,
but there were no significant differences among the
amphetamine-treated groups (average percent time spent
rearing, saline=2.1±0.75; 1 mg/kg=15.2±2.7; 2.5 mg/kg=
20.4±3.5; 5 mg/kg=16.8±7.7). No significant effect of
amphetamine on grooming was seen (main effect of dose:
F(3,12)=3.098, n.s.; Fig. 2b). Stereotypy was exclusively
observed in the group treated with 5 mg/kg of amphetamine
(average percent time spent in stereotypical behavior, 5 mg/
kg=28.4±16.5; all other groups average=0±0; Fig. 2b). A
clear main effect of dose was seen (F(3,12)=11.724; p<
0.005). The 5-mg/kg group differed significantly from all
other groups in the post hoc test.
Behavioral measures: responses to challenge after repeated
amphetamine
Pretreatment with amphetamine caused a clear-cut augmenta-
tion of the locomotor response to amphetamine, as illustrated
inFig.3a. Overall across the 90-min period, the AA group of
amphetamine-pretreated rats that were challenged with
amphetamine on the test day showed a 70% increase in
activity compared to the SA group, which was pretreated
with saline and challenged with amphetamine (total traveled
distance during the 90-min test period=20,432±3,403 cm by
AA compared to 11,924±2,149 cm by SA). Both groups that
were challenged with saline on the test day (AS and SS,
pretreated with amphetamine and saline, respectively)
Fig. 2 Locomotor activity (a) and behavioral observations (b) for
animals treated acutely with saline or 1, 2.5, or 5 mg/kg amphetamine.
The highest levels of locomotor activity were seen in the 2.5-mg/kg
treated group, which differed significantly from all other groups in the
post hoc tests. Stereotypical behavior was observed in the animals
treated with 5 mg/kg amphetamine, which differed significantly from
all other groups, but no stereotypy was seen in any of the other
treatment groups. No significant differences were seen in grooming
behavior (b). All amphetamine-treated groups showed significantly
more rearing than the saline-treated group (b), but the amphetamine
treatment groups did not differ from one another. Bars indicate group
averages, error bars represent SEM, n=4 per group. Asterisks indicate
significant difference in post hoc testing (p<0.05)
Fig. 3 Locomotor activity (a) and behavioral observations (b)i n
amphetamine-pretreated and amphetamine-challenged animals and
control groups. Bars represent group average of locomotor activity
(a) or percentage of time spent displaying each mutually exclusive
category of behavior (grooming, rearing or stereotypical behavior;
b). No bars are present representing stereotypical behavior because
this behavior was not observed in any animals included in this
experiment. Error bars indicate SEM, n=6 per group. AA
amphetamine-pretreated, amphetamine-challenged; SA saline-
pretreated, amphetamine-challenged; AS amphetamine-pretreated,
saline-challenged; SS saline-pretreated, saline-challenged. Asterisks
indicate significant difference in post hoc testing (p<0.05)
Psychopharmacology (2008) 198:113–126 117showed considerably less locomotor activity, showing
approximately 10% of the activity displayed by the AA
group (total traveled distance during 90 min, SS=1,770±
493 cm; AS=2,196±623 cm). These differences were
reflected in significant main effects of pretreatment (F(1,20)=
6.15; p<0.05) and challenge (F(1,20)=62.07;p<0.001),anda
significant pretreatment×challenge interaction (F(1,20)=
5.029; p<0.05).
As shown in Fig. 3b, the evaluation of the percentage of
time spent rearing revealed an increase in rearing in the AA
group compared to all other groups (average over 90 min,
AA=14.3±2.9%, AS=1.84±0.64%, SA=7.09±1.2%, SS=
3.34±0.92%). This was confirmed by a significant main
effect of challenge (F(1,20)=27.52; p<0.001) and pretreat-
ment×challenge interaction (F(1,20)=7.96; p<0.05). No
main effect of pretreatment was observed for this parameter
(F(1,20)=3.41; n.s.).
Percentages of time spent grooming were generally low
with average scores under 4% in all groups (average over
90 min, AA=1.66±0.64, AS=3.54±1.97, SA=1.78±0.86,
SS=3.97±0.87; Fig. 3b). Despite the somewhat higher
averages in the saline-challenged groups compared to the
amphetamine-challenged groups, no significant effects of
pretreatment, challenge, or interaction between the two
were seen on grooming (pretreatment: F(1,20)=0.64, n.s.;
challenge:F(1,20)=3.42, n.s.; pretreatment×challenge: F(1,20)=
0.21, n.s.).
No stereotyped behavior was observed in any animal in
any of the groups included in the repeated amphetamine
experiments during any of the time periods scored
(Fig. 3b).
Cellular reactivity results
In the nucleus accumbens and prefrontal cortex, the
quantification of c-fos positive nuclei was tested for
statistical significance by two-way ANOVAs using pre-
treatment and challenge as factors, followed by a Tukey
HSD post hoc. For brevity, results of these post hoc tests
are presented in the figures and in Table 1.
Sensitization alters distribution of reactivity in dorsal
striatum
In the dorsal striatum, visual inspection of the sections from
animals both pretreated and challenged with amphetamine
(AA group) showed overall more c-fos positive nuclei
compared to the AS group, and a differential distribution
throughout the area (Fig. 4). c-fos positive nuclei were more
abundant medially than laterally. Within the general
distribution, heterogeneity of reactivity was seen conform-
ing to patterns previously observed in patches in sensitized
animals. Comparison of c-fos staining pattern with μ-opioid
stained patches in sections from another series from the
same animals confirmed the location of high concentrations
of nuclei in μ-opioid stained patches.
Cellular reactivity sensitizes in nucleus accumbens core,
but not accumbens shell or prefrontal cortex
Within the nucleus accumbens, the core and shell sub-
divisions showed different c-fos immunoreactivity response
patterns to an amphetamine challenge after the sensitizing
regimen (Fig. 5a–d and Fig. 6). The core showed a clear
effect of sensitization with a number of c-fos positive nuclei
in the AA group 48% higher than that of the SA group and
more than 100% compared to both saline-challenged
groups (Fig. 6). Significant main effects of pretreatment
(F(1,28)=10.59; p<0.005) and challenge (F(1,28)=44.75; p<
0.001) and a significant pretreatment×challenge interaction
(F(1,28)=7.55; p<0.05) confirmed this observation. In the
nucleus accumbens shell, more c-fos positive nuclei were
counted in the amphetamine than saline-challenged groups,
but no sensitization effect was seen (Fig. 6). A significant
main effect of challenge (F(1,28)=4.41; p<0.05), but not of
pretreatment (F(1,28)=0.57; n.s.), was observed, and no
pretreatment×challenge interaction (F(1,28)=0.04; n.s.) was
present in the ANOVA of the nucleus accumbens shell data.
In the prefrontal cortex, an increase in c-fos positive
nuclei in amphetamine-challenged groups compared to
saline-challenged groups was observed in all four sub-
regions measured. No differences were seen between
amphetamine- and saline-pretreated animals in the number
of c-fos positive nuclei after an amphetamine challenge
(Fig. 6). Significant main effects of challenge were
observed in all areas (PL: F(1,28)=13.87, p<0.001; IL:
F(1,28)=6.94, p<0.05; orbital PFC: F(1,28)=25.96, p<0.001;
lateral PFC: F(1,28)=20.55, p<0.001). No significant effects
of pretreatment (PL: F(1,28)=0.14, n.s.; IL: F(1,28)=1.20, n.
s.; orbital PFC: F(1,28)=0.945, n.s.; lateral PFC: 0.79, n.s.)
or pretreatment×challenge interactions (PL: F(1,28)=0.08, n.
s.; IL: F(1,28)=0.037, n.s.; orbital PFC: F(1,28)=0.039; lateral
PFC: F(1,28)=0.67) were observed.
Frequency distributions of relative optical densities across
groups show sensitization of midrange in accumbens core
Whencomparing theROD of thec-fos positive nuclei of each
area across groups, significantly higher (=darker) averages
were seen in amphetamine- compared to saline-challenged
groups in the core (optical density 0.1216±0.0026 in saline-
challenged, 0.1372±0.0040 in amphetamine-challenged;
F(1,28)=10.815, p<0.005), the shell (optical density 0.1208±
0.0023 in saline-challenged, 0.1307±0.0035 in amphetamine-
challenged; F(1,28)=5.513, p<0.05), the infralimbic area
(intensity 0.7173±0.0057 in saline-challenged, 0.6985±
118 Psychopharmacology (2008) 198:113–1260.0660 in amphetamine-challenged; F(1,28)=4.368, p<0.05),
the orbital prefrontal area (intensity 0.7181±0.0048 in saline-
challenged, 0.6921±0.0073 in amphetamine-challenged;
F(1,28)=8.258, p<0.001), and the lateral prefrontal area
(intensity 0.7208±0.0045 in saline-challenged, 0.6992±
0.0067 in amphetamine-challenged; F(1,28)=6.753, p<0.05).
Significant differences were seen between the AA and SS
groups and between the SA and SS group in the core in post
hoc testing. No significant differences were seen in the shell
in post hoc testing.
The distributional patterns of the cellular ROD suggested
differences in the distributions of ROD across the treatment
groups. To further analyze the optical densities and
compare the frequencies of the various optical densities
between groups, histograms of the optical densities of all
cells per area, per group were constructed (Figs. 5e–f and
7a and b) and used to divide immunostained nuclei into
light, midrange, and dark optical density (OD) ranges based
on the 33rd and 66th percentile values in the SS group
(Table 1), as described in the “Materials and methods”
Table 1 Mean±SEM density (number of cells per mm
2)o fc - fos immunoreactive nuclei in light, dark, and midranges of cellular staining
intensity
Treatment group
AA AS SA SS
Nucleus accumbens Core Light 21.4±6.9 17.6±4.2 17.9±3.2 21.2±4.2
Midrange
§ 34.2±2.8
& 19.0±3.2
# 20.5±3.7 22.1±5.1
Dark
¶/**** 94.5±14.1
&/+ 35.6±4.6
# 61.2±12.4 24.1±3.6
#
Shell Light 28.8±8.7 26.9±7.3 28.8±5.9 38.3±6.4
Midrange 42.3±3.2 41.7±9.2 34.5±6.6 40.3±6.6
Dark
* 96.1±17.1 63.6±9.2 86.5±20.7 44.5±7.6
Prefrontal cortex Prelimbic Light 48.2±5.0 34.9±6.7 39.3±5.4 32.2±3.8
Midrange
** 50.0±6.9 31.0±6.0 46.4±7.0 27.7±6.3
Dark
*** 74.3±12.4 32.0±6.7
% 82.28±18.8
+/& 28.7±7.9
%
Infralimbic Light 37.6±3.8 33.1±5.8 30.4±5.6 29.9±5.1
Midrange 46.7±8.3 34.9±7.8 35.0±7.9 28.3±5.4
Dark
*** 78.1±13.7
+ 40.7±7.1 70.3±14.5 30.2±6.9
#
Orbital Light 27.8±3.6 24.7±6.1 23.0±4.3 21.0±4.4
Midrange
** 61.6±8.5
+ 32.6±7.7 45.0±8.4 30.7±5.9
#
Dark
**** 129.7±21.7
&/+ 32.6±8.6
# 120.4±24.2
+ 26.3±5.7
#/%
Lateral Light
* 22.8±2.3 14.8±10.0 18.1±2.8 14.4±3.3
Midrange
* 39.9±5.2 19.3±5.1 27.4±7.6 18.4±3.7
Dark
**** 69.5±11.6
&/+ 18.3±4.4
# 65.1±15.6
+ 16.7±4.6
#/%
Results of ANOVA testing are shown in the column indicating ROD range as follows: paragraph mark significant main effect of pretreatment,
asterisk significant main effect of challenge, section mark significant pretreatment×challenge interaction; one symbol: p<0.05, two symbols: p<
0.01, three symbols: p<0.005, four symbols: p<0.001. Results of post hoc testing are indicated in the cells containing the value of the average
number of nuclei as follows: plus sign significantly different from SS, percent sign significantly different from SA, ampersand significantly
different from AS, number sign significantly different from AA.
Fig. 4 Digital micrographs of c-
fos immunopositive nuclei in the
dorsal striatum of representative
animals from groups pretreated
with amphetamine and chal-
lenged with either saline (a,
group AS) or amphetamine (b,
group AA). Scale bars indicate
100 μm, arrows point to c-fos
immunopositive nuclei. Note the
higher number of c-fos positive
nuclei in the AA animal com-
pared to the SA animal, and the
inhomogeneous distribution of
nuclei in the AA animal
Psychopharmacology (2008) 198:113–126 119section. Two-way ANOVAs for pretreatment×challenge
were conducted, followed by Tukey HSD post hoc tests.
For brevity, the results of the post hoc tests are indicated in
Table 1.
In both the core and the shell, amphetamine-challenged
animals showed higher numbers of c-fos positive nuclei
than saline-pretreated animals in the dark range (core
challenge: F(1,28)=23.928, p<0.001; shell challenge:
F(1,28)=6.421, p<0.05). A significant effect of pretreatment
was seen in the core in this range (F(1,28)=5.202, p<0.05),
and no effect was seen in the shell (F(1,28)=0.949, n.s.). No
pretreatment×challenge interactions were observed in the
core (pretreatment×challenge: F(1,28)=1.227, n.s.; Fig. 7c
and Table 1) or shell (pretreatment×challenge: F(1,28)=
0.103, n.s.; Fig. 7d and Table 1) in this range. In the
midrange nuclei, the core area showed a distinct pattern of
distribution compared to all other areas measured as a
sensitization effect was confirmed by a significant pretreat-
ment×challenge interaction (F(1,28)=4.901, p<0.05;
Fig. 7c), while no significant main effects were observed
(pretreatment: F(1,28)=1.985, n.s.; challenge: F(1,28)=3.195,
n.s.). No differences between groups were observed in the
midrange nuclei in the shell (pretreatment: F(1,28)=0.474,
n.s.; challenge: F(1,28)=0.146, n.s.; pretreatment×challenge:
F(1,28)=0.229, n.s.; Fig. 7d). No differences between groups
were seen in the light range nuclei in the core (Fig. 7c;
pretreatment: F(1,28)=0.000, n.s.; challenge: F(1,28)=0.002,
n.s.; pretreatment×challenge: F(1,28)=0.532, n.s.) or the
shell (Fig. 7d; pretreatment: F(1,28)=0.624, n.s.; challenge:
F(1,28)=0.280, n.s.; pretreatment×challenge: F(1,28)=0.632,
n.s.).
Within the prefrontal cortex, the areas measured showed
a relatively homogenous pattern of distribution of c-fos
immunoreactivity across the OD ranges (Table 1). In the
Fig. 5 Digital micrographs of c-
fos immunopositive nuclei and
representations of nuclei quanti-
fied in the nucleus accumbens
from representative animals
treated acutely with amphet-
amine (SA group; a, c, and e)
and challenged with amphet-
amine after amphetamine pre-
treatment (AA group; b, d, and
f). The low magnification over-
views of nucleus accumbens in
a (SA animal) and b (AA
animal) show differences in the
number of c-fos immunopositive
nuclei between the two experi-
mental groups. Corresponding
detail images of the nucleus
accumbens core, shown in c
(detail from b) and d (detail
from b), are medial to anterior
commissure. Nuclei counted for
quantification in c and d are
illustrated in e and f, respec-
tively. Red squares indicate im-
munoreactive nuclei classified
as “dark,” green squares as
“midrange,” and blue squares as
“light” (see text for classifica-
tion procedures). Broad white
arrows in d and f indicate a
“dark” immunopositive nucleus
and its representation in the
counted nuclei; gray arrows
represent “midrange”; narrow
white arrows indicate “light.”
Scale bar in a indicates 300 μm
for a and b; scale bar in c
represents 100 μm for c and d.
cp caudate putamen, ac anterior
commissure, core nucleus
accumbens core, shell nucleus
accumbens shell
120 Psychopharmacology (2008) 198:113–126dark range, all areas showed significantly more c-fos
positive nuclei in the amphetamine-treated groups com-
pared to the saline-treated groups (main effect challenge:
PL: F(1,28)=14.974, p<0.005; IL: F(1,28)=11.563, p<0.005;
orbital: F(1,28)=31.370, p<0.001; lateral: F(1,28)=23.751,
p<0.001) but no effects of pretreatment (main effect
pretreatment: PL: F(1,28)=0.035, n.s.; IL: F(1,28)=0.645, n.
s.; orbital: F(1,28)=0.209, n.s.; lateral: F(1,28)=0.092, n.s.) or
interaction between pretreatment and challenge (pretreat-
ment×challenge: PL: F(1,28)=0.207, n.s.; IL: F(1,28)=0.014,
n.s.; orbital: F(1,28)=0.008, n.s.; lateral: F(1,28)=0.015, n.s.).
In the midrange, increased numbers of c-fos positive nuclei
in amphetamine-challenged animals were seen in the
prelimbic (F(1,28)=8.081, p<0.01), orbital (F(1,28)=7.941,
p<0.01), and lateral (7.029, p<0.05) areas, but not the
infralimbic area (F(1,28)=1.545, n.s.). No effects were seen
in the midrange segment of pretreatment (main effect
pretreatment: PL: F(1,28)=0.265, n.s.; IL: F(1,28)=1.511, n.
s.; orbital: F(1,28)=1.453, n.s.; lateral: F(1,28)=1.461, n.s.),
and no pretreatment×challenge interactions were seen
(pretreatment×challenge: PL: F(1,28)=0.001, n.s.; IL:
F(1,28)=0.113, n.s.; orbital: F(1,28)=0.928, n.s.; lateral:
F(1,28)=1.076, n.s.). In the light range, only the lateral
Fig. 6 Mean number of c-fos immunopositive nuclei in nucleus
accumbens core and shell and prelimbic, infralimbic, orbital, and lateral
prefrontal cortex. Two-way ANOVA analysis of accumbens data showed
significant main effects of pretreatment and challenge and a pretreat-
ment×challenge interaction in the nucleus accumbens core. A significant
effect of challenge was observed in the nucleus accumbens shell and for
all PFC areas measured. Bars represent the number of c-fos immuno-
positive nuclei per mm
2, error bars indicate SEM, n=8 per group.
Asterisk indicates significant differences in post hoc testing. See Fig. 3
for abbreviations of treatment groups
Fig. 7 Representations of distributions of optical densities in the nucleus
accumbens. In a and b, histograms of relative optical densities of
individual c-fos immunopositive nuclei in nucleus accumbens core (a)
and shell (b) are depicted. T1 and T2 lines represent the 33rd and 66th
percentile values, respectively, for the SS group. In the nucleus
accumbens core, the AA group shows more neurons in the midrange
segment (between T1 and T2), as confirmed by the analysis of number of
cells per segment (c). A significant pretreatment×challenge interaction is
present in the midrange of the nucleus accumbens core. The
amphetamine-challenged groups both contain more neurons in the dark
segment of both core (c)a n ds h e l l( d) compared to saline-challenged
groups, as evidenced by a significant effect of challenge in the ANOVA
test. No significant differences were observed in post hoc testing in the
shell; asterisks indicate significant differences in post hoc testing for core
in c (p<0.05). Line colors and patterns or bar fillings indicating groups
are as shown in a and c.F o rc and d, bars represent the number of c-fos
positive nuclei in each OD segment per mm
2, error bars indicate SEM,
n=8 per group. See Fig. 2 for abbreviations of treatment groups
Psychopharmacology (2008) 198:113–126 121prefrontal cortex showed a significant increase in c-fos
positive nuclei in the amphetamine-challenged groups
(main effect challenge: F(1,28)=4.228, p<0.05). No other
challenge effects were observed (main effect challenge: PL:
F(1,28)=3.751, n.s.; IL: F(1,28)=0.243, n.s.; orbital: F(1,28)=
0.302, n.s.). No effects of pretreatment (main effect
pretreatment: PL: F(1,28)=1.225, n.s.; IL: F(1,28)=1.060, n.
s.; orbital: F(1,28)=0.863, n.s.; lateral: F(1,28)=0.793, n.s.) or
of sensitization (pretreatment×challenge interaction: PL:
F(1,28)=0.356, n.s.; IL: F(1,28)=0.156, n.s.; orbital: F(1,28)=
0.015, n.s.; lateral: F(1,28)=0.573, n.s.) were seen in the
light range of the PFC c-fos immunopositive nuclei.
Discussion
In the present study, we set out to characterize the behavioral
response to amphetamine in drug-naive and amphetamine-
pretreated animals, as we had previously observed that
treatment with a high dose (5 mg/kg) of amphetamine in
drug-naive animals resulted in a similar pattern of cellular
reactivity in the dorsal striatum as a challenge with an
intermediate dose (1 mg/kg) in amphetamine-pretreated,
behaviorally sensitized rats (Vanderschuren et al. 2002).
Furthermore, we aimed to characterize the reactivity of
subregions within the nucleus accumbens and prefrontal
cortex during the expression of psychostimulant sensitiza-
tion. Our results showed that previously demonstrated
similarity of cellular activation patterns in the dorsal striatum
after amphetamine in sensitized or drug-naive rats was not
accompanied by similar behavioral responses. Thus, animals
given acute amphetamine at a dose that produces heightened
patch activation (5 mg/kg) displayed intense stereotypy,
which was not seen during the expression of sensitization at
a challenge dose (1 mg/kg) that also produces higher
activation of patches than surrounding matrix. Cellular
activation was sensitized in response to a drug challenge in
the nucleus accumbens core, but not the shell or the
prefrontal cortex. Examination of the distribution patterns
of the optical densities of the individual immunopositive
nuclei revealed an upward shift in the histograms of the core
in the AA group, resulting in a significant increase in the
midrange stained nuclei in the accumbens core in sensitized
animals.
Sensitization of locomotor activity and rearing
without stereotypy
After amphetamine pretreatment, an augmented locomotor
and rearing response to amphetamine was seen compared to
saline-pretreated, amphetamine-challenged animals, thus
supporting the notion that stereotypy and patch hyperreac-
tivity could take place independently. The behavioral pattern
of the amphetamine-pretreated, amphetamine-challenged
group most resembled the animals treated acutely with 1.0
or 2.5 mg/kg of amphetamine. No stereotyped behavior was
observed in the sensitized animals after an amphetamine
challenge, while intense stereotypy was seen in animals
treated acutely with 5 mg/kg of amphetamine. In our
previous paper (Vanderschuren et al. 2002), we noted that
t h ed e c r e a s ei nl o c o m o t i o nn o r m a l l yo b s e r v e di na n i m a l s
treated acutely with a high dose of amphetamine was likely a
result of stereotypy, an idea which is strengthened by the
present observations.
In previous studies by our laboratory and others, animals
treated acutely with the relatively high dose of 5 mg/kg of
amphetamine (Graybiel et al. 1990; Vanderschuren et al.
2002) or with the same amphetamine regimen for sensiti-
zation followed by a challenge with 1 mg/kg amphetamine
used in the present study (Vanderschuren et al. 2002) show
enhanced ratios of response in patches compared to the
matrix in the dorsal striatum, findings visually confirmed in
the present set of experiments. We concluded on the basis
of our previous results that the changes seen in striatal
reactivity represent a shift in sensitivity to amphetamine
rather than long-term adaptations in circuitry. If the
increased sensitivity to amphetamine underlying behavioral
sensitization paralleled the hyperreactivity of patches, the
same pattern of behavior would be expected in animals
showing similar immediate-early gene expression patterns,
namely, the 5-mg/kg acutely challenged group and the
amphetamine-sensitized, amphetamine-challenged group.
However, the expression of stereotypy in the 5-mg/kg
group, not seen in the sensitized animals, and the erratic
locomotor activity seen in the 5-mg/kg group, clearly
indicate behavioral differences after the two treatments. It
is interesting to note that the dissociation of hyperreactivity
of patches and sensitized behavioral responses manifests in
a lack of stereotypical behavior in sensitized animals, as
increased reactivity of patches compared to the matrix has
been suggested to underlie stereotypical behavior (Canales
and Graybiel 2000). Given the fact that the sensitization
regimen and challenge dose used in the present study
causes heightened patch to matrix ratios of c-fos expression,
but does not cause stereotyped behavior, changes in striatal
patterns of activity are apparently not causally related to
stereotypy.
Sensitization of immediate-early gene activation
in a specific neural population of the nucleus
accumbens core
The sensitized immediate-early gene expression we ob-
served in the nucleus accumbens core during the expression
of psychostimulant sensitization after a withdrawal period
of 14 days contradicts a number of previous immediate-
122 Psychopharmacology (2008) 198:113–126early gene studies where no sensitization effect was
observed in the core (Ostrander et al. 2003; Todtenkopf et
al. 2002a), including one study from our own laboratory
(Vanderschuren et al. 2002). There are two main differences
between the present study and the previous study from our
group. First, in our previous study, a 3-week abstinence
period was observed, while in the present study, animals
were tested after 14 days of abstinence. It is interesting to
note that studies examining immediate-early gene expres-
sion after shorter abstinence periods (2 days) do show
sensitization of reactivity within the core (Hedou et al.
2002; Todtenkopf et al. 2002a), indicating that abstinence
time is of potential importance for sensitization of c-fos in
the nucleus accumbens core. However, this explanation
seems unsatisfactory as the study by Totenkopf et al.
(2002a) also tested c-fos expression after 2 weeks of
abstinence and found no sensitization of c-fos expression
in the nucleus accumbens core. This discrepancy might be
explained by a second difference between the studies where
no effect was observed and the present study: in studies
finding no effect of sensitization on the nucleus accumbens
core, animals were at least partially pretreated and
challenged in the same environment. Exposure to amphet-
amine in a relatively novel environment has been shown to
potentiate the c-fos response to the drug in the nucleus
accumbens core (Ostrander et al. 2003).The importance of
the testing environment was recently underscored by a
study showing that sensitized c-fos responses to cocaine in
the nucleus accumbens only occurred when cocaine was
always administered in a discrete environment outside of
the home cage (Hope et al. 2006).
Expression of c-fos in the striatum can be elicited by
stimulation of dopamine receptors (Berretta et al. 1992),
which have been demonstrated to be crucially involved in
the expression of amphetamine sensitization (Vanderschuren
and Kalivas 2000). As mentioned in the “Introduction”,a
number of studies point to the sensitization of dopamine
transmission in the accumbens core during the expression of
sensitization (Cadoni et al. 2000; Phillips et al. 2003), and
increased dopamine is also seen in the core compared to
the shell in yoked controls in cocaine and heroin self-
administration studies (Lecca et al. 2007a; Lecca et al.
2007b). It is thus possible that dopamine may play a role in
eliciting the increased c-fos response seen in the accumbens
core in the present study.
In the accumbens core, more cells in the midrange of
optical densities were present in the amphetamine-
pretreated, amphetamine-challenged group than in all other
groups. This “upward” shift in sensitized animals, visible in
the histogram of optical density frequencies, indicates that
the increase in c-fos positive nuclei is not due to nuclei that
were under our detection threshold for c-fos increasing their
reactivity enough to be measured. In the case of increased
c-fos expression within the same population of nuclei that
normally respond to amphetamine, a rightward shift in the
histogram of optical densities would be expected, which
would manifest in a sensitization effect in the dark range
and increase of the average optical density. No increase was
seen in the overall average optical density, no significant
interaction observed between pretreatment and challenge in
the dark group, and there is no significant difference
between the AA and SA groups in the dark group.
However, an obvious trend to sensitization in the darkly
stained group is visible in Fig. 6. Although the lack of
significance precludes firm conclusions, it might be that
some neurons which normally respond to amphetamine by
producing c-fos react by producing more c-fos after
sensitization.
The increase of frequency of neurons stained in the
midrange without a significant shift in average optical
density suggests the recruitment of a new population of
nuclei becoming responsive to amphetamine in the sensi-
tized animals. The population most likely to be involved in
that sensitized response is the dopamine D2 receptor-
containing, enkephalin-positive population that project via
the subthalamic nucleus to the substantia nigra pars
reticulata and entopenduncular nucleus. Indeed, sensitiza-
tion of cocaine-induced c-fos expression in the nucleus
accumbens in animals treated with the drug in a discrete
environment was only found in enkephalin-positive cells,
but not in dynorphin-positive, dopamine D1 receptor-
expressing neurons that directly project to the substantia
nigra (Hope et al. 2006). Differences in responsivity to
amphetamine in these two cellular populations have also
been demonstrated in a study where dopamine D2 receptor-
containing neurons became activated when amphetamine is
administered in a novel environment (Badiani et al. 1999).
Remarkably, c-fos expression in dopamine D1 receptor-
containing accumbens neurons was shown to be important
for the induction of cocaine sensitization (Zhang et al.
2006), suggesting that these two different cell populations
play distinct roles in the induction and expression of
behavioral sensitization.
Immediate-early gene responses to acute amphetamine
in the nucleus accumbens shell and prefrontal cortex
The cellular response of the nucleus accumbens shell to
acute amphetamine, which did not sensitize after repeated
amphetamine, corresponds well with previous results from
our laboratory demonstrating the same effect (Vanderschuren
et al. 2002). The role of the shell in the expression of
psychostimulant sensitization is not clear-cut. On the one
hand, psychostimulant sensitization-induced long-term
changes in cellular reactivity or cellular morphology are
not generally found in the nucleus accumbens shell after
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2004; Todtenkopf et al. 2002a). Moreover, post induction
lesions of the shell leave the expression of cocaine
sensitization intact (Todtenkopf et al. 2002b), although
preinduction lesions of a subarea of the shell result in
reduced sensitized, but not acute responses to cocaine
(Brenhouse and Stellar 2006). On the other hand, microin-
jection of amphetamine or cocaine into the shell (but not
core) produces sensitized psychomotor responses and aug-
mented dopamine levels in animals pretreated with cocaine
(Filip and Siwanowicz 2001; Pierce and Kalivas 1995), and
sensitized cellular reactivity has been observed in specific
subareas within the accumbens shell after repeated cocaine
administration (Brenhouse et al. 2006; Todtenkopf et al.
2002a). Discrepancies between studies finding the effects of
sensitization in the shell and the present study could be due
to the use of cocaine pretreatment and/or challenges in other
studies and amphetamine pretreatment and challenge in the
present study. Cocaine and amphetamine have been observed
to produce different activation patterns in the dorsal striatum
with acute amphetamine producing activation of patches and
acute cocaine producing a more homogenous staining pattern
(Graybiel et al. 1990); it is possible that cocaine and
amphetamine pretreatment produce different patterns of
reactivity in the ventral striatum as well.
Within the prefrontal cortex, all areas showed c-fos
expression in response to amphetamine, but there was no
effect of amphetamine preexposure. To our knowledge, this
is the first examination of c-fos expression in orbital and
lateral prefrontal areas. However, the lack of sensitization
of c-fos expression in the medial prefrontal cortex cor-
responds well with results from other groups showing
similar results after 2 weeks of abstinence (Todtenkopf et
al. 2002a). Sensitization of c-fos immunoreactivity does
occur when animals are challenged after 2 days of
abstinence (Hedou et al. 2002; Todtenkopf et al. 2002a, b),
suggesting a role in the induction or early phases of
sensitization. In support of a role for the prefrontal cortex
in the induction and early phases of expression, lesion
studies have demonstrated region-specific effects in the
involvement of prefrontal areas in the induction of cocaine
sensitization (Tzschentke and Schmidt 2000), and lesions of
the entire medial prefrontal cortex have been shown to
prevent the induction of amphetamine sensitization (Wolf et
al. 1995; Cador et al. 1999, but see Tzschentke and Schmidt
2000). Studies examining expression of psychostimulant
sensitization suggest that the dorsal areas of the medial
prefrontal cortex that project to the nucleus accumbens core
are involved in the expression of psychostimulant sen-
sitization (Steketee 2003). Although no sensitization of
immediate-early gene expression was observed in the present
study, a dorsal–ventral gradient was seen in acute response to
amphetamine with the prelimbic area showing a 74%
increase in the SA group over the SS group and the
infralimbic area showing a smaller increase at 45%. The
high responsivity of lateral prefrontal neurons to amphet-
amine (114% increase in SA over SS) is also interesting in
this respect, as the projections from this area to the nucleus
accumbens are nearly exclusive to the nucleus accumbens
core (Berendse et al. 1992). The highly active prefrontal
cortical inputs projecting to the core may play a role in
enhancing the activation of the core during the expression of
sensitization.
Remarkably, the highest responsivity to acute amphet-
amine was found in the orbital frontal area, a prefrontal
cortex area that projects primarily to the dorsal striatum and
only very sparsely to the nucleus accumbens (Berendse et
al. 1992). Metabolic and structural changes within the
orbital prefrontal cortex have been demonstrated in human
drug addicts and nonhuman primates and rodents with a
history of drug self-administration (Crombag et al. 2005;
Porrino and Lyons 2000; Volkow and Li 2004). A recent
study showed that rats sensitized to cocaine are impaired on
a task that is sensitive to orbital prefrontal lesions
(Schoenbaum et al. 2004). The high responsivity of this
area to acute amphetamine indicates that corticostriatal
circuits not involving the nucleus accumbens also play an
important role in the acute response to amphetamine.
In conclusion, challenging animals sensitized to amphet-
amine with a dose of the drug that produces preferential
activation of dorsal striatal patches did not produce
stereotyped behavior, unlike the behavioral pattern ob-
served in animals treated acutely with a dose of amphet-
amine that causes the same pattern of neural activation.
Sensitized immediate-early gene activity was found in the
nucleus accumbens core, but not the accumbens shell or the
prefrontal cortex. The gradients observed in the present
study in cellular responses to amphetamine in subareas of
the prefrontal cortex with specific afferents to the nucleus
accumbens suggest a specific role for various corticostriatal
loops in the behavioral responses to psychostimulant drugs,
further supporting the importance of accumbens–prefrontal
cortex interactions in drug addiction (Volkow and Li 2004;
Robbins and Everitt 2002).
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